The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) have?

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) has 161 citations in the OpenAlex counts ScholarIQ stores.

When was The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) published?

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) has 2021 year in the ScholarIQ index.

What is the open-access status of The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)?

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) has gold oa status in the ScholarIQ index.

What is the DOI of The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)?

The DOI for The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) is on the source record.

What is the PMID of The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)?

The PMID for The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) is on the source record.

What is the OpenAlex record for The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)?

The OpenAlex for The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) is on the source record.